申请人:Ligand Pharmaceuticals Inc.
公开号:EP2489656A1
公开(公告)日:2012-08-22
Provided herein are compounds of formulae I to II that bind to androgen receptors and/or modulate activity of androgen receptors; and to methods for making and using such compounds. Also provided are compositions including such compounds and methods for making and using such compositions.
本文提供了与雄激素受体结合和/或调节雄激素受体活性的式 I 至式 II 化合物;以及制造和使用此类化合物的方法。还提供了包括此类化合物的组合物以及制造和使用此类组合物的方法。